simplywall.stWhile shareholders of Teva Pharmaceutical Industries (NYSE:TEVA) are in the black over 3 years, those who bought a week ago aren't so fortunate4 days agoMore
TipRanksTeva Pharmaceutical’s Strategic Edge and Growth Potential: Analyst Recommends Buy Rating3 days agoMore
Full Coverage